Government Pension Fund Global (Norway) bought 6,26,000 shares of Biocon for ₹25.04 Cr at ₹400.00 apiece in a block deal. This occurred during a larger block deal where Mylan Inc. sold its entire 5.64% stake in Biocon.
A leading biotechnology company engaged in the manufacture of innovative pharmaceutical products and research services across multiple therapeutic areas. Biocon specializes in biologics, biosimilars, and small molecule drugs, serving patients in oncology, immunology, and diabetes therapeutics globally. The company operates integrated manufacturing facilities and maintains a strong commitment to developing affordable healthcare solutions for patients in emerging markets worldwide.
Norway's sovereign wealth fund, managed by Norges Bank Investment Management. World's largest SWF with over USD 2 trillion in assets, invested across 8,700+ companies globally including Indian equities.
